Paulson Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
Paulson Wealth Management's GILD Position: Q1 2026 in Review
Paulson Wealth Management reduced its Gilead Sciences (GILD) stake by 1.2% in Q1 2026, selling an estimated $6.72K and leaving 3,839 shares worth $535K. The position accounts for 0.13% of the portfolio, ranked #74.
Paulson Wealth Management first reported a position in GILD in Q4 2017 and has held it in 20 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Paulson Wealth Management held 3,839 shares of Gilead Sciences worth $535K as of Q1 2026.
- Paulson Wealth Management sold 48 Gilead Sciences shares in Q1 2026, an estimated $6.72K.
- Gilead Sciences made up 0.13% of Paulson Wealth Management's portfolio in Q1 2026, its #74 holding.
- Paulson Wealth Management first reported a position in Gilead Sciences in Q4 2017 and has held it in 20 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Paulson Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.